Immunogenicity and safety of the human papillomavirus vaccine in young survivors of cancer in the USA: a single-arm, open-label, phase 2, non-inferiority trial.
Saved in:
| Title: | Immunogenicity and safety of the human papillomavirus vaccine in young survivors of cancer in the USA: a single-arm, open-label, phase 2, non-inferiority trial. |
|---|---|
| Authors: | Landier W; Institute for Cancer Outcomes and Survivorship, Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: wclandier@uabmc.edu., Bhatia S; Institute for Cancer Outcomes and Survivorship, Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Wong FL; Department of Population Sciences, City of Hope, Duarte, CA, USA., York JM; Institute for Cancer Outcomes and Survivorship, Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Flynn JS; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA., Henneberg HM; Institute for Cancer Outcomes and Survivorship, Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Singh P; Institute for Cancer Outcomes and Survivorship, Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Adams K; Institute for Cancer Outcomes and Survivorship, Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Wasilewski-Masker K; Department of Pediatrics, Emory University and Children's Healthcare of Atlanta, Atlanta, GA, USA., Cherven B; Department of Pediatrics, Emory University and Children's Healthcare of Atlanta, Atlanta, GA, USA., Jasty-Rao R; Division of Pediatric Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA., Leonard M; Division of Pediatric Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA., Connelly JA; Department of Pediatrics, Vanderbilt University, Nashville, TN, USA., Armenian SH; Department of Population Sciences, City of Hope, Duarte, CA, USA., Robison LL; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA., Giuliano AR; Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center, Tampa, FL, USA., Hudson MM; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA., Klosky JL; Department of Pediatrics, Emory University and Children's Healthcare of Atlanta, Atlanta, GA, USA. |
| Source: | The Lancet. Child & adolescent health [Lancet Child Adolesc Health] 2022 Jan; Vol. 6 (1), pp. 38-48. Date of Electronic Publication: 2021 Nov 10. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Equivalence Trial |
| Journal Info: | Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101712925 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-4650 (Electronic) Linking ISSN: 23524642 NLM ISO Abbreviation: Lancet Child Adolesc Health Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34767765 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immunogenicity and safety of the human papillomavirus vaccine in young survivors of cancer in the USA: a single-arm, open-label, phase 2, non-inferiority trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Landier+W%22">Landier W</searchLink>; Institute for Cancer Outcomes and Survivorship, Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: wclandier@uabmc.edu.<br /><searchLink fieldCode="AU" term="%22Bhatia+S%22">Bhatia S</searchLink>; Institute for Cancer Outcomes and Survivorship, Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Wong+FL%22">Wong FL</searchLink>; Department of Population Sciences, City of Hope, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22York+JM%22">York JM</searchLink>; Institute for Cancer Outcomes and Survivorship, Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Flynn+JS%22">Flynn JS</searchLink>; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA.<br /><searchLink fieldCode="AU" term="%22Henneberg+HM%22">Henneberg HM</searchLink>; Institute for Cancer Outcomes and Survivorship, Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Singh+P%22">Singh P</searchLink>; Institute for Cancer Outcomes and Survivorship, Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Adams+K%22">Adams K</searchLink>; Institute for Cancer Outcomes and Survivorship, Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Wasilewski-Masker+K%22">Wasilewski-Masker K</searchLink>; Department of Pediatrics, Emory University and Children's Healthcare of Atlanta, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Cherven+B%22">Cherven B</searchLink>; Department of Pediatrics, Emory University and Children's Healthcare of Atlanta, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Jasty-Rao+R%22">Jasty-Rao R</searchLink>; Division of Pediatric Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Leonard+M%22">Leonard M</searchLink>; Division of Pediatric Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Connelly+JA%22">Connelly JA</searchLink>; Department of Pediatrics, Vanderbilt University, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Armenian+SH%22">Armenian SH</searchLink>; Department of Population Sciences, City of Hope, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Robison+LL%22">Robison LL</searchLink>; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA.<br /><searchLink fieldCode="AU" term="%22Giuliano+AR%22">Giuliano AR</searchLink>; Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Hudson+MM%22">Hudson MM</searchLink>; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA.<br /><searchLink fieldCode="AU" term="%22Klosky+JL%22">Klosky JL</searchLink>; Department of Pediatrics, Emory University and Children's Healthcare of Atlanta, Atlanta, GA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101712925%22">The Lancet. Child & adolescent health</searchLink> [Lancet Child Adolesc Health] 2022 Jan; Vol. 6 (1), pp. 38-48. <i>Date of Electronic Publication: </i>2021 Nov 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Equivalence Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Ltd%22">Elsevier Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101712925 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2352-4650 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223524642%22">23524642 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Child Adolesc Health <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34767765 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S2352-4642(21)00278-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 38 Titles: – TitleFull: Immunogenicity and safety of the human papillomavirus vaccine in young survivors of cancer in the USA: a single-arm, open-label, phase 2, non-inferiority trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Landier W – PersonEntity: Name: NameFull: Bhatia S – PersonEntity: Name: NameFull: Wong FL – PersonEntity: Name: NameFull: York JM – PersonEntity: Name: NameFull: Flynn JS – PersonEntity: Name: NameFull: Henneberg HM – PersonEntity: Name: NameFull: Singh P – PersonEntity: Name: NameFull: Adams K – PersonEntity: Name: NameFull: Wasilewski-Masker K – PersonEntity: Name: NameFull: Cherven B – PersonEntity: Name: NameFull: Jasty-Rao R – PersonEntity: Name: NameFull: Leonard M – PersonEntity: Name: NameFull: Connelly JA – PersonEntity: Name: NameFull: Armenian SH – PersonEntity: Name: NameFull: Robison LL – PersonEntity: Name: NameFull: Giuliano AR – PersonEntity: Name: NameFull: Hudson MM – PersonEntity: Name: NameFull: Klosky JL IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2022 Jan Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2352-4650 Numbering: – Type: volume Value: 6 – Type: issue Value: 1 Titles: – TitleFull: The Lancet. Child & adolescent health Type: main |
| ResultId | 1 |
